Renal xenografts from triple-transgenic pigs are not hyperacutely rejected but cause coagulopathy in non-immunosuppressed baboons

Transplantation

Volumn 69, Issue 12, 2000, Pages 2504-2515

  Cowan, Peter J ^a   Aminian, Atousa ^a   Barlow, Helen ^a   Brown, Ainslie A ^a   Chen, Chao Guang ^a,b   Fisicaro, Nella ^a   Francis, David M A ^a,d   Goodman, David J ^a   Han, Wenruo ^a,d   Kurek, Margarita ^a   Nottle, Mark B ^a,c   Pearse, Martin J ^a,b   Salvaris, Evelyn ^a   Shinkel, Trixie A ^a   Stainsby, Gerard V ^a,d   Stewart, Andrew B ^a   D'Apice, Anthony J F ^a  

^a ST VINCENT S HOSPITAL   (Australia)

^b CSL LIMITED   (Australia)

^c PO Box 259 Rundle Mall   (Australia)

^d ROYAL MELBOURNE HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

LOW MOLECULAR WEIGHT HEPARIN;

ANIMAL EXPERIMENT; ARTICLE; B LYMPHOCYTE; BABOON; BLOOD CLOTTING TIME; CELL INFILTRATION; CONTROLLED STUDY; IMMUNE DEFICIENCY; KIDNEY ALLOGRAFT REJECTION; KIDNEY FUNCTION; NONHUMAN; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; SWINE; T LYMPHOCYTE; THROMBOCYTOPENIA; XENOGRAFT;

EID: 18544404547     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-200006270-00008     Document Type: Article

References (50)

1. Platt JL, Fischel RJ, Matas AJ, Reif SA, Bolman RM, Bach FH. Immunopathology of hyperacute xenograft rejection in a swine-to-primate model. Transplantation 1991; 52: 214.
2. Nagayasu T, Platt JL. A perspective on xenotransplantation. Graft 1999; 2: S152.
3. Bach FH, Robson SC, Winkler H, et al. Barriers to xenotransplantation. Nature Med 1995; 1: 869.
4. Good AH, Cooper DKC, Malcolm AJ, et al. Identification of carbohydrate structures that bind human antiporcine antibodies: implications for discordant xenografting in humans. Transplant Proc 1992; 24: 559.
5. Galili U. Interaction of the natural anti-Gal antibody with a-galactosyl epitopes: a major obstacle for xenotransplantation in humans. Immunol Today 1993; 14: 480.
6. Oriol R, Ye Y, Koren E, Cooper DKC. Carbohydrate antigens of pig tissues reacting with human natural antibodies as potential targets for hyperacute vascular rejection in pig-to-man organ xenotransplantation. Transplantation 1993; 56: 1433.
7. Lambrigts D, Sachs DH, Cooper DKC. Discordant organ xenotransplantation in primates. Transplantation 1998; 66: 547.
8. Platt JL, Lin SS, McGregor CGA. Acute vascular rejection. Xenotransplantation 1998; 5: 169.
9. Bach FH, Winkler H, Ferran C, Hancock WW, Robson SC. Delayed xenograft rejection. Immunol Today 1996; 17: 379.
10. Lin SS, Weidner BC, Byrne GW, et al. The role of antibodies in acute vascular rejection of pig-to-baboon cardiac transplants. J Clin Invest 1998; 101: 1745.
11. Bach FH, Robson SC, Ferran C, et al. Endothelial cell activation and thromboregulation during xenograft rejection. Immunol Rev 1994; 141: 5.
12. Pearse MJ, Witort E, Mottram P, et al. Anti-Gal antibody-mediated allograft rejection in α1,3-galactosyltransferase gene knockout mice-a model of delayed xenograft rejection. Transplantation 1998; 66: 748.
13. Blakely ML, Vanderwerf WJ, Berndt MC, Dalmasso AP, Bach FH, Hancock WW. Activation of intragraft endothelial and mononuclear cells during discordant xenograft rejection. Transplantation 1994; 58: 1059.
14. Robson SC, Kaczmarek E, Siegel JB, et al. Loss of ATP diphosphohydrolase activity with endothelial cell activation. J Exp Med 1997; 185: 153.
15. Saadi S, Holzknecht RA, Patte CP, Stern DM, Platt JL. Complement-mediated regulation of tissue factor activity in endothelium. J Exp Med 1995; 182: 1807.
16. Peerschke EIB, Reid KBM, Ghebrehiwet B. Platelet activation by C1q results in the induction of αIIb/β3 integrins (GPIIb-IIIa) and the expression of P-selectin and procoagulant activity. J Exp Med 1993; 178: 579.
17. Ierino FL, Kozlowski T, Siegel JB, et al. Disseminated intravascular coagulation in association with the delayed rejection of pig-to-baboon renal xenografts. Transplantation 1998; 66: 1439.
18. Kozlowski T, Shimizu A, Lambrigts D, et al. Porcine kidney and heat transplantation in baboons undergoing a tolerance induction regimen and antibody adsorption. Transplantation 1999; 67: 18.
19. Cowan PJ, Shinkel TA, Aminian A, et al. High-level co-expression of complement regulators on vascular endothelium in transgenic mice: CD55 and CD59 provide greater protection from human complement-mediated injury than CD59 alone. Xenotransplantation 1998; 5: 184.
20. Cowan PJ, Chen CG, Shinkel TA, et al. Knock-out of α1,3 galactosyltransferase or expression of α1,2 fucosyltransferase further protects CD55- and CD59-expressing mouse hearts in an ex vivo model of xenograft rejection. Transplantation 1998; 65: 1599.
21. Cozzi E, Tucker AW, Langford GA, et al. Characterization of pigs transgenic for human decay-accelerating factor. Transplantation 1997; 64: 1383.
22. Zaidi A, Schmoeckel M, Bhatti F, et al. Life-supporting pig-to-primate renal xenotransplantation using genetically modified donors. Transplantation 1998; 65: 1584.
23. Schmoeckel M, Bhatti FNK, Zaidi A, et al. Orthotopic heart transplantation in a transgenic pig-to-primate model. Transplantation 1998; 65: 1570.
24. Kroshus TJ, Bolman RM, Dalmasso AP, et al. Expression of human CD59 in transgenic pig organs enhances organ survival in an ex vivo xenogeneic perfusion model. Transplantation 1996; 61: 1513.
25. Diamond LE, McCurry KR, Martin MJ, et al. Characterization of transgenic pigs expressing functionally active human CD59 on cardiac endothelium. Transplantation 1996; 61: 1241.
26. Byrne G, McCurry KR, Martin MJ, McClellan SM, Platt JL, Logan JS. Transgenic pigs expressing human CD59 and decay-accelerating factor produce an intrinsic barrier to complementmediated damage. Transplantation 1997; 63: 149.
27. McCurry KR, Parker W, Cotterell AH, et al. Humoral responses to pig-to-baboon cardiac transplantation: implications for the pathogenesis and treatment of acute vascular rejection and for accommodation. Hum Immunol 1997; 58: 91.
28. Chen RH, Naficy S, Logan JS, Diamond LE, Adams DH. Hearts from transgenic pigs constructed with CD59/DAF genomic clones demonstrate improved survival in primates. Xenotransplantation 1999; 6: 194.
29. Koike C, Kannagi R, Takuma Y, et al. Introduction of α(1,2)-fucosyltransferase and its effect on a-Gal epitopes in transgenic pig. Xenotransplantation 1996; 3: 81.
30. Sharma A, Okabe J, Birch P, et al. Reduction in the level of Gal(α1,3)Gal in transgenic mice and pigs by the expression of an α(1,2)fucosyltransferase. Proc Natl Acad Sci USA 1996; 93: 7190.
31. Chen CG, Fisicaro N, Shinkel TA, et al. Reduction in Gal- α1,3-Gal epitope expression in transgenic mice expressing human H-transferase. Xenotransplantation 1996; 3: 69.
32. van Denderen BJW, Pearse MJ, Nottle MB, et al. Expression of functional decay-accelerating factor (CD55) in transgenic mice protects against human complement-mediated attack. Transplantation 1996; 61: 582.
33. Nottle MB, Nagashima H, Kashiwazaki N, et al. Production of pigs containing a metallothionein porcine growth hormone gene construct. Abstract 33, Proc 26th Ann Conf Aust Soc Reprod Biol, 1994.
34. Cowan PJ, Somerville CA, Shinkel TA, et al. High-level endothelial expression of human CD59 prolongs heart function in an ex vivo model of xenograft rejection. Transplantation 1998; 65: 826.
35. Chen CG, Salvaris E, Romanella M, et al. Transgenic expression of human α1,2-fucosyltransferase (H-transferase) prolongs mouse heart survival in an ex vivo model of xenograft rejection. Transplantation 1998; 65: 832.
36. Shinkel TA, Chen CG, Salvaris E, et al. Changes in cell surface glycosylation in α1,3-galactosyltransferase knock out and α1,2-fucosyltransferase transgenic mice. Transplantation 1997; 64: 197.
37. Thurin J, Blaszczyk-Thurin M. Porcine submaxillary gland GDP-L-fucose: α-D-galactoside β-2-L-fucosyltransferase is likely a counterpart of the human Secretor gene-encoded blood group transferase. J Biol Chem 1995; 270: 26577.
38. Levi M, ten Gate H. Disseminated intravascular coagulation. N Engl J Med 1999; 341: 586.
39. Meyer C, Wolf P, Romain N, et al. Use of von Willebrand diseased kidney as donor in a pig-to-primate model of xenotransplantation. Transplantation 1999; 67: 38.
40. Tanemura M, Galili U. Differential expression of the α-Gal epitope on pig and mouse organs. Abstract 33, The 5th Congress of the International Xenotransplantation Society 1999, Nagoya, Japan.
41. Koike C, Katayama A, Kadomatsu K, et al. Reduction of α-Gal epitopes in transgenic pig by introduction of human α1-2 fucosyltransferase. Transplant Proc 1997; 29: 894.
42. Tearle RG, Tange MJ, Zannettino ZL, et al. The α-1,3-galactosyltransferase knockout mouse-implications for xenotransplantation. Transplantation 1996; 61: 13.
43. Yeatman M, Daggett CW, Parker W, et al. Complement-mediated pulmonary xenograft injury-studies in swine-to-primate orthotopic single lung transplant models. Transplantation 1998; 65: 1084.
44. Schmoeckel M, Bhatti FNK, Zaidi A, et al. Splenectomy improves survival of HDAF transgenic pig kidneys in primates. Transplant Proc 1999; 31: 961.
45. Kopp CW, Siegel JB, Hancock WW, et al. Effect of porcine endothelial tissue factor pathway inhibitor on human coagulation factors. Transplantation 1997; 63: 749.
46. Siegel JB, Grey ST, Lesnikoski B-A, et al. Xenogeneic endothelial cells activate human prothrombin. Transplantation 1997; 64: 888.
47. Schulte AM, Esch J II, Cruz MA, Siegel JB, Anrather J, Robson SC. Activation of human platelets by the membrane-expressed Al domain of von Willebrand Factor. Blood 1997; 90: 4425.
48. de Jonge E, Levi M, Stoutenbeek CP, van Deventer SJ. Current drug treatment strategies for disseminated intravascular coagulation. Drugs 1998; 55: 767.
49. Chen D, Riesbeck K, Kemball-Cook G, et al. Inhibition of tissue factor-dependent and independent coagulation by cell surface expression of novel anticoagulant fusion proteins. Transplantation 1999; 67: 467.
50. Chen D, Riesbeck K, McVey JH, et al. Regulated inhibition of coagulation by porcine endothelial cells expressing P-selectin-tagged hirudin and tissue factor pathway inhibitor fusion proteins. Transplantation 1999; 68: 832.